Addus HomeCare (NASDAQ:ADUS – Get Free Report)‘s stock had its “outperform” rating reiterated by analysts at Royal Bank of Canada in a report issued on Thursday,Benzinga reports. They currently have a $136.00 target price on the stock. Royal Bank of Canada’s target price points to a potential upside of 13.54% from the company’s current price.
Several other research firms also recently commented on ADUS. Stephens lifted their price objective on Addus HomeCare from $143.00 to $145.00 and gave the stock an “overweight” rating in a report on Wednesday, November 6th. Oppenheimer upped their target price on Addus HomeCare from $140.00 to $145.00 and gave the stock an “outperform” rating in a report on Monday, September 23rd. Macquarie reiterated an “outperform” rating and set a $139.00 target price on shares of Addus HomeCare in a report on Monday, November 4th. TD Cowen upped their target price on Addus HomeCare from $128.00 to $137.00 and gave the stock a “buy” rating in a report on Thursday, August 8th. Finally, KeyCorp assumed coverage on Addus HomeCare in a report on Friday, October 11th. They set an “overweight” rating and a $150.00 target price on the stock. One analyst has rated the stock with a sell rating, eight have issued a buy rating and one has issued a strong buy rating to the stock. According to MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $131.63.
Check Out Our Latest Research Report on Addus HomeCare
Addus HomeCare Price Performance
Addus HomeCare (NASDAQ:ADUS – Get Free Report) last released its earnings results on Monday, November 4th. The company reported $1.30 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.28 by $0.02. The business had revenue of $289.80 million during the quarter, compared to the consensus estimate of $289.42 million. Addus HomeCare had a return on equity of 9.62% and a net margin of 6.50%. The business’s revenue for the quarter was up 7.1% on a year-over-year basis. During the same period last year, the business posted $1.03 earnings per share. As a group, analysts anticipate that Addus HomeCare will post 4.58 earnings per share for the current year.
Insider Activity at Addus HomeCare
In other news, EVP Michael D. Wattenbarger sold 21,917 shares of the stock in a transaction on Monday, August 26th. The stock was sold at an average price of $133.29, for a total transaction of $2,921,316.93. Following the transaction, the executive vice president now directly owns 7,215 shares of the company’s stock, valued at $961,687.35. This represents a 75.23 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, Director Esteban Lopez sold 500 shares of the stock in a transaction on Wednesday, September 4th. The shares were sold at an average price of $130.03, for a total value of $65,015.00. Following the transaction, the director now directly owns 3,866 shares in the company, valued at $502,695.98. The trade was a 11.45 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders have sold 22,917 shares of company stock valued at $3,050,082. 4.60% of the stock is owned by corporate insiders.
Institutional Investors Weigh In On Addus HomeCare
Several hedge funds and other institutional investors have recently modified their holdings of ADUS. UMB Bank n.a. increased its stake in shares of Addus HomeCare by 64.2% in the 2nd quarter. UMB Bank n.a. now owns 225 shares of the company’s stock worth $26,000 after purchasing an additional 88 shares in the last quarter. Quarry LP purchased a new stake in shares of Addus HomeCare in the 3rd quarter worth $28,000. Quest Partners LLC purchased a new stake in shares of Addus HomeCare in the 2nd quarter worth $31,000. EntryPoint Capital LLC purchased a new stake in Addus HomeCare in the 1st quarter worth $44,000. Finally, Innealta Capital LLC purchased a new stake in Addus HomeCare in the 2nd quarter worth $44,000. 95.35% of the stock is currently owned by hedge funds and other institutional investors.
Addus HomeCare Company Profile
Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.
Read More
- Five stocks we like better than Addus HomeCare
- Unveiling The Power Of VWAP: A Key Indicator For Traders
- How Whitestone REIT Is Transforming Sun Belt Retail Growth
- What is the Australian Securities Exchange (ASX)
- Top-Performing Non-Leveraged ETFs This Year
- What to Know About Investing in Penny Stocks
- Rivian’s Wild Ride: Is the Dip a Buying Opportunity?
Receive News & Ratings for Addus HomeCare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Addus HomeCare and related companies with MarketBeat.com's FREE daily email newsletter.